Bert Tjeenk Willink

BERT TJEENK WILLINK, MD

Advisor and Venture Partner

Bert has more than 30 years of experience within the pharmaceutical industry.

Most recently, Bert served as the Chairman of Executive Board and CEO of STADA Arzneimittel Aktiengesellschaft.

He currently holds non-executive roles as the Chairman of the Advisory Board at Allecra Therapeutics GmbH and Lipid Therapeutics GmbH, and as the Chairman of the Board at BiosanaPharma B.V.

Prior to 2012, Bert spent 18 years at Boehringer Ingelheim GmbH, where he last served as a member of the Board of Managing Directors in charge of the Corporate Board Division Marketing and Sales in human pharmaceuticals. He was responsible for the business area Prescription Medicine and Consumer Health Care and held various other senior positions as the Country Manager of Mexico, Head of Marketing & Sales Canada, Regional Manager for North America, Head of Corporate Health Economics and Medical Director of The Netherlands.

Bert holds a degree in Medicine from the Erasmus University Rotterdam School of Medicine and is a member of the Royal College of Pharmaceutical Industry Physicians.

He is fluent in English, Dutch and German

Edward Willems

EDWARD WILLEMS

Managing Director & Co-founder

Ginger Hsiao

GINGER HSIAO

Co-founder

Shang Hsiao

SHANG HSIAO, JD, CPA

Co-founder and Venture Partner

FUMIAKI YUMOTO, PhD

Country Head Japan, Managing Director

HA LINH NGUYEN, PhD

Technical Analyst

EMILIEN DUGRAND, PharmD

Technical Analyst

LYANNE CHIN, PhD, RD

Technical Analyst

SHENGYANG JIN, PhD

Technical Analyst

NAO YOSHIZAWA

Advisor

KOUHEI TSUMOTO, PhD

Scientific Advisor

Andrew Lin

ANDREW LIN, MBA

Advisor

Clark Su

CLARK SU, MBA

Advisor

Adam Kirby

ADAM KIRBY

Advisor

Jerry Hong

JERRY HONG

Advisor